Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Alzamend Neuro, Inc. (ALZN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsApr-30-23Jan-31-23Oct-31-22Jul-31-22Apr-30-22Jan-31-22Oct-31-21Jul-31-21
   10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
OPERATING EXPENSES          
Research and development  1.62.91.51.41.70.91.80.9
General and administrative  1.72.51.61.72.21.71.81.4
    Total operating expenses  3.35.43.13.03.92.63.62.3
    Loss from operations  -3.3-5.4-3.1-3.0-3.9-2.6-3.6-2.3
   
OTHER INCOME (EXPENSE), NET          
Interest expense  0.00.00.00.00.00.00.00.0
Gain on extinguishment of debt          
    Total other income (expense), net  0.00.00.00.00.00.00.00.0
    NET LOSS  -3.3-5.4-3.1-3.0-3.9-2.6-3.6-2.3
   
Basic net loss per common share  ($0.03)($0.06)($0.03)($0.03)($0.05)($0.03)($0.04)($0.03)
Diluted net loss per common share  ($0.03)($0.06)($0.03)($0.03)($0.05)($0.03)($0.04)($0.03)
   
Basic weighted average common shares outstanding  97.598.397.597.589.194.293.584.6
Diluted weighted average common shares outstanding  97.598.397.597.589.194.293.584.6

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy